logo

For the Inventor, By the Inventor

Brisbane, CA, United States of America

Sarcode Bioscience Inc.

USPTO Granted Patents = 25



Trademarks = 1

Forward Citations = 398

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal John P Burnier (12 out of 33 patents)

silverMedal Wang Shen (10 out of 45 patents)

bronzeMedal Min Zhong (10 out of 41 patents)

4.  Johan D Oslob (10 out of 38 patents)

5.  Kenneth Jay Barr (10 out of 44 patents)

6.  Thomas Gadek (8 out of 67 patents)

7.  Frederic Naud (4 out of 5 patents)

8.  James Robert Zeller (4 out of 13 patents)

9.  Sripathy Venkatraman (4 out of 10 patents)

10.  Elisabeth C A Brot (3 out of 8 patents)

11.  Subashree Iyer (3 out of 4 patents)

12.  Michael Hall (3 out of 12 patents)

13.  Scott Tweedie (1 out of 5 patents)

14.  Charles Semba (2 patents)

15.  Min Zhong (0 patent)


Core Competencies:
Continuous Flow Carboxylation
LFA-1 Inhibitor
Cellular Adhesion Modulators
Crystalline Pharmaceutical
Treatment Compositions
Polymorph Preparation
Eye Disorders Treatment
Methods of Preparation

25 patents:

1. 10273212 - Continuous flow carboxylation reaction (2019-04-30),
2. 10214517 - LFA-1 inhibitor and methods of preparation and polymorph thereof (2019-02-26),
3. 10188641 - Compositions and methods for treatment (2019-01-29),
4. 10124000 - Modulators of cellular adhesion (2018-11-13),
5. 9890141 - Crystalline pharmaceutical and methods of preparation and use thereof (2018-02-13),
6. 9708303 - LFA-1 inhibitor and methods of preparation and polymorph thereof (2017-07-18),
7. 9447077 - Crystalline pharmaceutical and methods of preparation and use thereof (2016-09-20),
8. 9353088 - Crystalline pharmaceutical and methods of preparation and use thereof (2016-05-31),
9. 9248126 - Modulators of cellular adhesion (2016-02-02),
10. 9216174 - Modulators of cellular adhesion (2015-12-22),
11. 9085553 - LFA-1 inhibitor and methods of preparation and polymorph thereof (2015-07-21),
12. 9051297 - Compositions and methods for treatment (2015-06-09),
13. 9045458 - Compositions and methods for treatment (2015-06-02),
14. 9045457 - Compositions and methods for treatment (2015-06-02),
15. 8927574 - Crystalline pharmaceutical and methods of preparation and use thereof (2015-01-06),
Company Overview
Sarcode Bioscience Inc. is a biotechnology company based in Brisbane, California, specializing in the development of innovative therapies for various medical conditions. The organization focuses on harnessing advanced biopharmaceutical technologies to create solutions that address unmet medical needs. With a commitment to research and development, Sarcode aims to advance the field of medicine through its specialized expertise in drug discovery and development, contributing to improved patient outcomes and healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#5 in Brisbane, CA

#3,158 in California

#13,370 in US

#25,730 in the World

Brisbane, CA (US)
Brisbane, CA, United States of America

Sarcode Bioscience Inc.

Forward Citations = 398

13 inventors:

goldMedal John P Burnier (12 out of 33 patents)

silverMedal Wang Shen (10 out of 45 patents)

bronzeMedal Min Zhong (10 out of 41 patents)

4.  Johan D Oslob (10 out of 38 patents)

5.  Kenneth Jay Barr (10 out of 44 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sarcode Bioscience Inc.. Retrieved from https://idiyas.com/company/sarcode-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…